Kalytera Therapeutics

Developer of cannabinoid therapies for osteoporosis and bone healing

placeSan Rafael, California, United States calendar_todayFounded 2014 language kalytera.co

Innovation

1 patent family — focus: Chemistry & metallurgy; filing pace dormant. Cited 5 times.

YearFilings
20181

Investor mix

2 investors on record; 1 has since exited.

Investor typeCountShare
Private equity150%
Other / undisclosed150%
Coming soon